Possible HIV/AIDS Vaccine Breakthrough - Still More To Do

01.07.13 | By

The search for a HIV/AIDS vaccine goes on. Word of a possible breakthrough last week is encouraging.

Possible HIV/AIDS Vaccine Breakthrough – Still More To Do

01.07.13 | By

The search for a HIV/AIDS vaccine goes on.  Word of a possible breakthrough last week is encouraging.  But, while welcome news, it should be taken with a grain of salt  – it is still no cure.

Speech: John J. Castellani Remarks at National Journal Forum

Remarks
John J. Castellani
President & C.E.O.
Pharmaceutical Research and Manufacturers of America
Before: National Journal Forum
Conditions for Progress: Strengthening America’s Health Care Ecosystem
Tuesday, November 13, 2012
Washington, D.C. 

Thank you, Victoria and good morning.

Rx Minute: Offsets in Heart Failure Treatment & Seniors Selecting Lower Costs Part D Plans

November 2012

Last month, a study published in the American Journal of Managed Care found a significant association between modest increases in adherence to heart failure (HF) medications and reduced medical spending among Medicare beneficiaries.[1]

Rotary International and Global Partners Contribute to a Polio-Free India

Washington, D.C. (November 3, 2012) — The Pharmaceutical Research and Manufacturers of America (PhRMA) and its members are pleased to celebrate one of the most significant global health achievements of the 21st century.  For over the past three years, we have supported Rotary International’s PolioPlus program in India through grants and contributions, some of which have been matched by the Bill and Melinda Gates Foundation. 

PhRMA Statement on Bloomberg Article

Washington, D.C. (September 19, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

PhRMA Statement on Avalere Health Analysis on Medicare Part D Premiums

Washington, D.C. (September 25, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on findings from Avalere Health on Medicare Part D premiums:

Speech: John J. Castellani National Press Club Remarks

Remarks
John J. Castellani
President & CEO
Pharmaceutical Research and Manufacturers of America
The National Press Club
Washington, D.C.
Thursday, September 20, 2012

 

Thank you, Keith for that kind introduction. And my thanks to all of you here for joining me this morning.

Researchers and Patient Advocates Honored with PhRMA Award

Washington, D.C. (September 7, 2012)— The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year’s award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care for Alzheimer’s disease.

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

Washington, D.C. (June 18, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today:

Pages

Subscribe to RSS - Opinion